Floatz logo

Keyhole Limpet Hemocyanin

Relapsing Multiple Sclerosis

Novartis Pharmaceuticalsprotein_peptidePhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

79 Active assets in the Relapsing Multiple Sclerosis cohort.

Asset / SponsorPhaseRating
Fingolimod
TG Therapeutics, Inc.
Phase 4A
Natalizumab
Biogen
Phase 4BBB
Glatiramer
University Hospital, Montpellier
Phase 4BBB
Interferon ?1 (human fibroblast protein moiety)
Biogen
Phase 4BBB
Ocrevus
Biocad
Phase 4BBB

View all 50 →

Same molecule, other indications

Keyhole Limpet Hemocyanin is also rated in:

giant cell glioblastomaDormant
BB
Indicative ·
66 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
62 / 100
View asset →
gliosarcomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →